Heavy-period drug can treat brain haemorrhage

Who it going to put 2 and 2 together and get this written up into stroke protocols and distribute it to all the stroke hospitals in the world? I'm guessing no one since we have NO STROKE LEADERSHIP ANYWHERE.  

Did your incompetent stroke hospital DO ANYTHING with ANY of this earlier research? 

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): An international randomised, placebo-controlled, phase 3 superiority trial

May 2018, this one actually supposedly was negative.

 

Drug to treat bleeding may benefit some stroke patients, study finds May 2018

 

The Lancet: Immediate treatment with clot-stabilising drug could save thousands of additional lives every year November 2017

 

Treatment of intracerebral haemorrhage with tranexamic acid – A review of current evidence and ongoing trials October 2016

 

New guidance for administering hemorrhage prevention treatment August 2016

 

UBC researchers create self-propelled powder to stop bleeding October 2015

 

UC to Study New Drug in Patients with Traumatic Brain Injury June 2014

 

University of Nottingham to study use of tranexamic acid in people with intracerebral haemorrhage March 2013

I bet they will incompetently DO NOTHING because it is easier to wait for SOMEONE ELSE TO SOLVE THE PROBLEM?   

The latest here for your stroke hospital and doctors to ignore. 

Heavy-period drug can treat brain haemorrhage

A drug used for heavy periods could benefit patients with strokes caused by dangerous brain bleeds, experts says.

Currently, there is no effective drug treatment.
A trial in The Lancet found tranexamic acid stemmed bleeding and reduced the risk of death in the early days following a haemorrhagic stroke.
Although it did not equate to less disability at three months, researchers are still hopeful about its use as a stroke therapy.

Brain bleeds

Up to a fifth of strokes are bleeds.
They account for nearly a half of all stroke deaths worldwide.
Those who do survive may be left with debilitating disabilities, including paralysis and difficulty with their speech.

• Sir Alex Ferguson out of intensive care after brain bleed
• Stroke patients getting younger
• How to spot the signs of a stroke before it happens

Carolyn Danby was 32 when she had a stroke. She had been out Christmas shopping at the time.
"I felt almost a bit of a head rush," she says. "I didn't quite feel right.
"I went to pick up a gift bag with my left hand and I couldn't grasp it. I knew something was wrong. I felt like I was drunk really. My left leg started to drag. I was panicking."
She tried to ask for help, but the words wouldn't come out.
"I was trying to say, 'Please help me, something is wrong,'" she says. "I could say it in my head, but I just couldn't say it."
An emergency scan at hospital revealed Carolyn had a bleed on her brain.
She was offered the option to take part in the tranexamic acid trial and accepted. She still doesn't know if she received the drug itself or a dummy injection, but she has made a good recovery.

Image caption Dr Sprigg examining Carolyn's brain scan

Half of the 2,325 people who took part in the trial were given tranexamic acid and the other half were given a placebo so that the researchers could reliably measure what effect the treatment had.
Researcher Dr Nikola Sprigg, from the University of Nottingham, said: "Tranexamic acid is a drug that has been around for a long time. It's effective in other bleeding conditions."
It is already used (in tablets) for treating heavy periods and (by injection) for controlling dangerous bleeding during childbirth or severe trauma.
"In the stroke patients it reduced the amount of bleeding in the brain," Dr Sprigg said. "It also reduced the amount of people that died in the first week after bleeding, which is the emergency period."
Less bleeding should mean less damage and disability, and fewer deaths.
But the study did not find any difference between the two patient groups on these measures at three months.
Prof Sprigg said: "Future work is going to need to focus on getting patients to hospital quicker and getting the treatment quicker - probably within three or four hours."
The Stroke Association, which funded earlier stages of the trial, said: "Currently, treatment for haemorrhagic stroke is very limited so we are excited by the findings of this study into bleeding that happens within the brain. We hope there will now be further research into how this relatively cheap and widely available drug could be used to potentially save lives and improve long-term recovery from this type of stroke. "